Cytokinetics (CYTK) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Cytokinetics, as the data feed reports them.

Analysts' mean target, 19 analysts
$109.42
111.9% above the price

The 19 analysts reported by the data feed have a mean price target for Cytokinetics of $109.42, 111.9% above the $51.65 price (range $78.00–$146.00). 19.65% of the float was sold short as of Oct 30, 2026. Institutions hold 132.1% of the shares and insiders 0.6%. Source: Yahoo Finance, read Nov 18, 2026.

Key facts

Analysts' mean target
$109.42+111.9% vs price
Analysts
19
Short interest
19.65%of float, Oct 30, 2026
Short ratio
10.04 days
Institutions
132.1%
Insiders
0.58%
Beta
0.47

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

19 analysts covering Cytokinetics, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $51.65.

Analysts' price targets for Cytokinetics
Mean price target$109.42111.9% above the price (+111.9%)
Median price target$107.00107.2% above the price (+107.2%)
Highest target$146.00182.7% above the price (+182.7%)
Lowest target$78.0051.0% above the price (+51.0%)
Analysts with a target19

Ratings this month · 22 analysts

Strong buy 7(32%)Buy 13(59%)Hold 2(9%)
Analysts' ratings of Cytokinetics this month, by rating
RatingAnalystsShare
Strong buy732%
Buy1359%
Hold29%
Sell00%
Strong sell00%

The feed averages these to 1.5 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Cytokinetics

Ownership of Cytokinetics
Held by institutions132.1%644 institutions; percent of shares outstanding
Held by institutions, of the float132.9%
Held by insiders0.58%percent of shares outstanding
Shares outstanding139.3M
Float138.78Mshares available to trade
Insiders' net purchases, six months−13.43K48 purchases (322.41K shares), 35 sales (335.84K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Cytokinetics
Shares short17.93Mas of Oct 30, 2026
Percent of float19.65%shares short ÷ float
Percent of shares outstanding12.88%shares short ÷ shares outstanding
Short ratio (days to cover)10.04shares short ÷ average daily volume

Cytokinetics short interest from FINRA, with its history

Trading figures

Trading figures for Cytokinetics
Beta0.47movement against the market; 1 moves with it
52-week high$88.31
52-week low$51.38
Average volume, 3 months2Mshares a day
Average volume, 10 days2.7Mshares a day

Questions and answers

What is the analysts' price target for Cytokinetics (CYTK)?

As reported by the data feed, the mean price target of the 19 analysts covering Cytokinetics is $109.42, 111.9% above the latest price of $51.65. The highest target is $146.00 and the lowest $78.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Cytokinetics stock?

Of the 22 ratings the data feed reports for the current month, 7 are strong buy, 13 buy, 2 hold, 0 sell and 0 strong sell.

How many Cytokinetics shares are sold short?

As reported by the data feed, 17.93M shares were sold short, 19.65% of the float as of Oct 30, 2026. At the average daily volume that is 10.04 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Cytokinetics stock?

As reported by the data feed, institutions hold 132.1% of the shares (644 institutions) and insiders 0.6%. There are 139.3M shares outstanding, of which 138.78M are in the float.

How much does Cytokinetics stock move with the market?

Its beta, as reported by the data feed, is 0.47: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $51.38 and $88.31.

Cite this page

Funkfolio, “Cytokinetics (CYTK) statistics: analyst targets and short interest”, data as of 18 November 2026. https://funkfolio.com/stock/CYTK/statistics

Underlying data: Yahoo Finance.